Stivarga (regorafenib) 40 mg film-coated tablets, 84 tablets — generic (Natco, India) Targeted cancer therapy. Drug delivery from Europe within 4-5 days, guaranteed storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Indications

Regorafenib is indicated for the treatment of patients with metastatic colorectal cancer (CRC) previously treated with fluoropyrimidine-based chemotherapy, oxaliplatin, and irinotecan, anti-VEGF therapy, and, in the case of wild-type KRAS, anti-EGFR therapy. Regorafenib is also indicated for the treatment of patients with locally advanced, unresectable, or metastatic gastrointestinal stromal tumor (GIST) previously treated with imatinib mesylate and sunitinib malate. Regorafenib is also indicated for the treatment of patients with hepatocellular carcinoma (HCC) previously treated with sorafenib.2